Lupisulin R 100IU/ml Cartridge contains human insulin at a concentration of 100 IU per milliliter, indicated for the management of diabetes mellitus requiring insulin therapy. This rapid-acting insulin formulation is designed to facilitate glycemic control by promoting cellular glucose uptake and inhibiting hepatic glucose production. Administered subcutaneously using an insulin pen device, Lupisulin R allows for flexible dosing tailored to individual patient needs, including prandial glucose regulation. Onset of action typically occurs within 30 minutes, with peak activity between 2 to 4 hours and a duration of approximately 6 to 8 hours, making it suitable for mealtime glucose management. The cartridge format ensures compatibility with standard reusable insulin pens, enhancing convenience and adherence. Lupisulin R should be used under medical supervision, with dosage adjustments based on blood glucose monitoring and patient response. Caution is advised to avoid hypoglycemia, the most common adverse effect, and patients should be educated on recognizing and managing low blood sugar episodes. This product is contraindicated in patients with hypersensitivity to human insulin or any excipients. Proper storage between 2°C and 8°C is essential to maintain potency. Lupisulin R 100IU/ml Cartridge is a reliable option for effective insulin therapy in diabetes management.